CSI Market
Sign In | Register

Astria Therapeutics Inc (ATXS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ATXS quarterly Cash Flow →
From Astria Therapeutics Inc through Dec 31 2020, changes in Dec 31 2024's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Operating Activities
Income-94.26
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation13.04
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Services Received In Non Monetary Exchange-
Non Cash Portion Of Acquired Research And Development-
Gain Loss On Warrant Inherited-
Increase Decrease In Right Of Use Asset Operating-0.73
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable2.81
Increase (Decrease) in Accrued Liabilities3.72
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.25
Other Working Capital0.00
Other Noncash Income (Expense)0.07
Other net0.00
Payments for (Proceeds from) Other Operating Activities-4.61
Discontinued operations0.00
Net Cash flow from Operating Activities-81.21
Investing Activities
Capital Expenditures-0.33
Sale of Capital Items0.00
Short-term Investments Proceeds-191.54
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-191.86
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock117.17
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net4.79
Proceeds From Stock Options Exercised And Warrants Exercised-
Payment Of Deferred Initial Public Offering Costs-
Proceeds From Issuance Of At Market Offering35.25
Proceeds From Exercise Of Stock Options And Warrant Financial Activities-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities157.20
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-81.54
Total Cash Flow-115.87
4 historic quarters locked

Sign in to unlock the full Astria Therapeutics Inc cash flow history.

Sign In Create Free Account

About Astria Therapeutics Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001410578-25-000309

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License